Luliconazole
1%
Common side effects of this medication are Application Site Redness, Skin Burn, Irritation, Itching.
The potential of luliconazole to inhibit cytochrome P-450 (CYP) enzymes 1A2, 2C9, 2C19, 2D6, and 3A4 was evaluated in vitro. Based on in vitro assessment, luliconazole at therapeutic doses, particularly when applied to patients with moderate to severe tinea cruris, may inhibit the activity of CYP2C19 and CYP3A4. However, no in vivo drug interaction trials have been conducted to evaluate the effect of luliconazole on other drugs that are substrates of CYP2C19 and CYP3A4
The half life of Luliconazole in Lucoz Cream is yet to be detemined
For pregnant or potentially pregnant women, use only if the therapeutic benefit outweighs the risks. [Safety for use during pregnancy has not been established. ]
Safety has not been established for low birth weight infants, newborns, infants, toddlers or children. [No experience with low birth weight infants and newborns, and little experience with infants, toddlers and children. ]
Subscribe to our newsletter and be the first to receive insights, updates, and expert tips on optimizing your financial management.